Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi. Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan). 2024
Akihiro Nakashima, Hideya Yamazaki, Gen Suzuki, Kei Yamada, Aibe Norihiro, Takuya Kimoto, Koji Masui, Katsuhiko Nakatsuka, Tetsuya Taguchi, Yasuto Naoi. The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery. Cureus. 2023. 15. 11. e48187
Yasuto Naoi, Ryo Tsunashima, Kenzo Shimazu, Masahiro Oikawa, Seiichi Imanishi, Hiroshi Koyama, Yoshihiko Kamada, Kazuhiro Ishihara, Masahiko Suzuki, Tomo Osako, et al. Validation of the prognosis of patients with ER-positive, HER2-negative and node-negative invasive breast cancer classified as low risk by CurebestTM 95GC Breast in a multi-institutional registry study. Oncology letters. 2023. 25. 5. 209-209